THC Biomed Intl Ltd
THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under t… Read more
THC Biomed Intl Ltd (THCBF) - Total Liabilities
Latest total liabilities as of April 2023: $9.02 Million USD
Based on the latest financial reports, THC Biomed Intl Ltd (THCBF) has total liabilities worth $9.02 Million USD as of April 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
THC Biomed Intl Ltd - Total Liabilities Trend (2001–2022)
This chart illustrates how THC Biomed Intl Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
THC Biomed Intl Ltd Competitors by Total Liabilities
The table below lists competitors of THC Biomed Intl Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Saxon Capital Group Inc
PINK:SCGX
|
USA | $64.29K |
|
Hanna Capital Corp
F:04U1
|
Germany | €563.39K |
|
SurgePays Inc. Warrant
NASDAQ:SURGW
|
USA | $8.22 Million |
|
O.R.T.
TA:ORTC
|
Israel | ILA7.31 Million |
|
Blackrock Multi Sector Income Closed Fund
NYSE:BIT
|
USA | $336.08 Million |
|
Brightstar Lottery PLC
NYSE:BRSL
|
USA | $7.93 Billion |
|
Southern BancShares (N.C.) Inc. PFD CV B
PINK:SBNCM
|
USA | $3.44 Billion |
Liability Composition Analysis (2001–2022)
This chart breaks down THC Biomed Intl Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.92 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how THC Biomed Intl Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for THC Biomed Intl Ltd (2001–2022)
The table below shows the annual total liabilities of THC Biomed Intl Ltd from 2001 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-07-31 | $7.81 Million | +2.63% |
| 2021-07-31 | $7.61 Million | +10.31% |
| 2020-07-31 | $6.90 Million | +49.91% |
| 2019-07-31 | $4.60 Million | +103.21% |
| 2018-07-31 | $2.27 Million | -54.55% |
| 2017-07-31 | $4.98 Million | +298.62% |
| 2016-07-31 | $1.25 Million | -55.06% |
| 2015-07-31 | $2.78 Million | +378.42% |
| 2014-07-31 | $581.52K | -14.30% |
| 2013-07-31 | $678.58K | +51.09% |
| 2012-07-31 | $449.14K | +27.51% |
| 2011-07-31 | $352.23K | +107.90% |
| 2010-07-31 | $169.42K | +68.96% |
| 2009-07-31 | $100.28K | +157.84% |
| 2008-07-31 | $38.89K | -45.22% |
| 2007-07-31 | $70.99K | +114.28% |
| 2006-07-31 | $33.13K | -37.52% |
| 2005-07-31 | $53.03K | -8.59% |
| 2004-07-31 | $58.01K | +0.32% |
| 2003-07-31 | $57.82K | +14.19% |
| 2002-07-31 | $50.64K | -36.82% |
| 2001-07-31 | $80.15K | -- |